Epitope-specific CD4+, but not CD8+, T-cell responses induced by recombinant influenza A viruses protect against Mycobacterium tuberculosis infection. (Q41645299)

From Wikidata

Jump to navigation Jump to search

scientific article published on 23 December 2014

Language	Label	Description	Also known as
English	Epitope-specific CD4+, but not CD8+, T-cell responses induced by recombinant influenza A viruses protect against Mycobacterium tuberculosis infection.	scientific article published on 23 December 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25430701%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Epitope-specific CD4+, but not CD8+, T-cell responses induced by recombinant influenza A viruses protect against Mycobacterium tuberculosis infection (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25430701%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Mycobacterium tuberculosis

1 reference

based on heuristic

inferred from title

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25430701%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Caitlin M Gillis

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25430701%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Stephen J. Turner

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25430701%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

author name string

Manuela Flórido

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25430701%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Roman Pillay

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25430701%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Yingju Xia

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25430701%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

James A Triccas

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25430701%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Warwick J Britton

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25430701%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

language of work or name

0 references

publication date

23 December 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25430701%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

European Journal of Immunology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25430701%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

45

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25430701%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25430701%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

780-793

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25430701%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Vaccination against tuberculosis: how can we better BCG?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444954

21 January 2018

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444954

21 January 2018

Mycobacterium tuberculosis-specific CD8+ T cells and their role in immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444954

21 January 2018

Activation of CD8 T cells by mycobacterial vaccination protects against pulmonary tuberculosis in the absence of CD4 T cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444954

21 January 2018

Next generation: tuberculosis vaccines that elicit protective CD8+ T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444954

21 January 2018

Induction of CD8+ T-lymphocyte responses to a secreted antigen of Mycobacterium tuberculosis by an attenuated vaccinia virus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444954

21 January 2018

Priming by DNA immunization augments protective efficacy of Mycobacterium bovis Bacille Calmette-Guerin against tuberculosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444954

21 January 2018

Single intranasal mucosal Mycobacterium bovis BCG vaccination confers improved protection compared to subcutaneous vaccination against pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444954

21 January 2018

Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444954

21 January 2018

Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guérin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444954

21 January 2018

Immunization by a bacterial aerosol

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444954

21 January 2018

Mucosal delivery of antigen-coated nanoparticles to lungs confers protective immunity against tuberculosis infection in mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444954

21 January 2018

Mucosal vaccination against tuberculosis using inert bioparticles

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444954

21 January 2018

TLR2-targeted secreted proteins from Mycobacterium tuberculosis are protective as powdered pulmonary vaccines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444954

21 January 2018

Evaluation of the safety and immunogenicity of a candidate tuberculosis vaccine, MVA85A, delivered by aerosol to the lungs of macaques

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444954

21 January 2018

Influenza A virus infection impairs mycobacteria-specific T cell responses and mycobacterial clearance in the lung during pulmonary coinfection.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444954

21 January 2018

Immune markers and correlates of protection for vaccine induced immune responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444954

21 January 2018

Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444954

21 January 2018

Control of chronic mycobacterium tuberculosis infection by CD4 KLRG1- IL-2-secreting central memory cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444954

21 January 2018

Lung niches for the generation and maintenance of tissue-resident memory T cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444954

21 January 2018

Delayed protection by ESAT-6-specific effector CD4+ T cells after airborne M. tuberculosis infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444954

21 January 2018

Cutting edge: Direct recognition of infected cells by CD4 T cells is required for control of intracellular Mycobacterium tuberculosis in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444954

21 January 2018

Impact of HIV infection on the epidemiology of tuberculosis in a peri-urban community in South Africa: the need for age-specific interventions

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444954

21 January 2018

Depletion of CD4(+) T cells causes reactivation of murine persistent tuberculosis despite continued expression of interferon gamma and nitric oxide synthase 2

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444954

21 January 2018

CD4 T cell depletion exacerbates acute Mycobacterium tuberculosis while reactivation of latent infection is dependent on severity of tissue depletion in cynomolgus macaques

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444954

21 January 2018

Cutting edge: Tissue-retentive lung memory CD4 T cells mediate optimal protection to respiratory virus infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444954

21 January 2018

Lung-resident memory CD8 T cells (TRM) are indispensable for optimal cross-protection against pulmonary virus infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444954

21 January 2018

Harnessing local and systemic immunity for vaccines against tuberculosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444954

21 January 2018

Simultaneous immunization against tuberculosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444954

21 January 2018

Live attenuated influenza vaccine (FluMist®; Fluenz™): a review of its use in the prevention of seasonal influenza in children and adults

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444954

21 January 2018

Engineering influenza viral vectors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444954

21 January 2018

Evaluation of recombinant influenza virus-simian immunodeficiency virus vaccines in macaques

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444954

21 January 2018

Recombinant influenza virus carrying the respiratory syncytial virus (RSV) F85-93 CTL epitope reduces RSV replication in mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444954

21 January 2018

Polyfunctional CD8(+) T cells are associated with the vaccination-induced control of a novel recombinant influenza virus expressing an HCV epitope.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444954

21 January 2018

A recombinant influenza A virus expressing domain III of West Nile virus induces protective immune responses against influenza and West Nile virus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444954

21 January 2018

Induction of protective CD4+ T cell-mediated immunity by a Leishmania peptide delivered in recombinant influenza viruses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444954

21 January 2018

Recombinant viruses expressing a human malaria antigen can elicit potentially protective immune CD8+ responses in mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444954

21 January 2018

Influenza virus NS vectors expressing the mycobacterium tuberculosis ESAT-6 protein induce CD4+ Th1 immune response and protect animals against tuberculosis challenge.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444954

21 January 2018

Antigen-specific CD8+ T cells and the development of central memory during Mycobacterium tuberculosis infection.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444954

21 January 2018

The HyVac4 subunit vaccine efficiently boosts BCG-primed anti-mycobacterial protective immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444954

21 January 2018

Comparing adjuvanted H28 and modified vaccinia virus ankara expressingH28 in a mouse and a non-human primate tuberculosis model

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444954

21 January 2018

Protection against tuberculosis with homologous or heterologous protein/vector vaccine approaches is not dependent on CD8+ T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444954

21 January 2018

High-frequency vaccine-induced CD8⁺ T cells specific for an epitope naturally processed during infection with Mycobacterium tuberculosis do not confer protection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444954

21 January 2018

Vaccine-elicited 10-kilodalton culture filtrate protein-specific CD8+ T cells are sufficient to mediate protection against Mycobacterium tuberculosis infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444954

21 January 2018

A critical role for CD8 T cells in a nonhuman primate model of tuberculosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444954

21 January 2018

Prime-boost vaccination with rBCG/rAd35 enhances CD8⁺ cytolytic T-cell responses in lesions from Mycobacterium tuberculosis-infected primates

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444954

21 January 2018

Relative contributions of distinct MHC class I-dependent cell populations in protection to tuberculosis infection in mice.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444954

21 January 2018

A DNA transfection system for generation of influenza A virus from eight plasmids

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444954

21 January 2018

Narrowed TCR diversity for immunised mice challenged with recombinant influenza A-HIV Env(311-320) virus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444954

21 January 2018

Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444954

7 January 2021

based on heuristic

inferred from DOI database lookup

Nanoparticle conjugation and pulmonary delivery enhance the protective efficacy of Ag85B and CpG against tuberculosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444954

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccine-induced anti-tuberculosis protective immunity in mice correlates with the magnitude and quality of multifunctional CD4 T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444954

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of in vivo T lymphocyte subset depletion on mycobacterial infections in mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444954

7 January 2021

based on heuristic

inferred from DOI database lookup

Antigen Load Governs the Differential Priming of CD8 T Cells in Response to the Bacille Calmette Guerin Vaccine or Mycobacterium tuberculosis Infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444954

7 January 2021

based on heuristic

inferred from DOI database lookup

Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444954

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41645299&oldid=1535802290"